Pain |
Mice |
Inosine |
10–300 mg/kg/i.p. and p.o. 10 μg/i.c.v./i.t. |
Inosine mediates reduction time of licking in the formalin test, inhibition of glutamate-induced nociception, reduction mechanical allodynia and hyperalgesia |
Nascimento et al., 2010
|
Pain |
Mice |
Inosine |
10 mg/kg/i.p. |
Inosine promotes antinociception through pertussis toxin sensitive G-protein coupled receptors and voltage gated K+ channel, large conductance Ca2+-activated and ATP-sensitive K+ channels or inactivation of voltage-gated Ca2+ channels |
Macedo-Junior et al., 2013
|
Pain |
Mice |
Inosine |
10 and 100 mg/kg/i.p |
Inosine reduces flinching behavior induced by formalin and systemic and central nociception in A1-wild type mice |
Nascimento et al., 2015
|
Pain |
Mice |
Inosine |
200–600 nmol/i.t. |
Inosine inhibits nociceptive response induced by injection of capsaicin and increases ATP, ADP, AMP, adenosine, inosine, hypoxanthine, xanthine, and uric acid CSF levels |
de Oliveira et al., 2016
|
Learning and memory |
Rat |
Inosine |
100 and 200 mg/kg/i.p. |
Learning and memory improvement, levels of TNF-alpha reduction, antioxidant properties increment |
Ruhal and Dhingra, 2018
|
Epilepsy |
Rat |
Inosine |
500 and 1000 mg/kg, i.p. |
Inosine increases number and total time of spike-waves discharges |
Kovács et al., 2015a, b
|
Epilepsy |
Mice |
Inosine |
400 nmol/4 μl, i.c.v. |
Inosine protect against quinolinic-acid induced seizures |
Ganzella et al., 2011
|
Alzheimer |
Rat |
Inosine |
100 mg/kg, i.c.v. |
Inosine induces memory deficit prevention and AChE activity reduction |
Teixeira et al., 2020
|
Parkinson |
Dopaminergic cells culture |
Inosine |
— |
H2O2-toxic effect on dopaminergic cells reduction, indicators of free radical generation and oxidative damage in MES 23.5-astrocytes co-cultures were reduced |
Cipriani et al., 2010
|
Parkinson |
Human |
Inosine |
500 mg; p.o. |
Average serum urate increment (more pronounced in woman), reduction of motor symptoms in UPDRS scale |
Schwarzschild et al., 2019
|
Neural regeneration |
Goldfish |
Inosine |
50 and 100 μM |
Inosine increases retinal ganglion cells neuronal outgrowth and GAP-43 levels |
Petrausch et al., 2000
|
Neural regeneration |
PC12 cells and neuronal embryonic cells Sprague-Dawley rat fetuses |
Inosine |
100 μM – 1 mM |
Inosine activates Mst3b kinase activity |
Irwin et al., 2006
|
Anxiety |
Mice |
Inosine |
10 – 300 mg/kg, i.p. |
Inosine antagonizes anxiety-reducing actions of benzodiazepines |
Crawley et al., 1981
|
Anxiety |
Mice |
Inosine |
10 – 60 mg/kg, s.c. |
Inosine presents anxiolytic effect in the Vogel-type anti-conflict test |
Okuyama et al., 1998
|
Depression |
Mice |
Inosine |
10 mg/kg, i.p. |
Inosine reduces mice immobility time in the forced swim test and in the tale suspension test |
Kaster et al., 2013
|
Depression |
Human |
Inosine plasma levels |
— |
Inosine plasma levels are significantly higher in individuals treated with antidepressant drugs when compared to healthy individuals |
Zhou et al., 2019
|